About us|Cardiac Arrest|LUCAS CPR|For users|News & Media|Contact|

News archive

Scientific study provides new support for Jolife – results point to improved survival rates with LUCAS

19th of December 2007 Lund, Sweden

Jolife, which develops and markets LUCAS, a mechanical chest compression system used to resuscitate patients following cardiac arrest, has received support in a new study conducted at Brugmann University Hospital in Brussels. The study shows that more than twice as many patients regain blood flow and heart function when LUCAS is used in situations of sudden cardiac arrests.

The study of LUCAS was conducted at Brugmann University Hospital in Brussels, Belgium and published in the French language publication Urgences & Accueil. The study included 150 patients suffering sudden cardiac arrest. Every cardiac arrest event included occurred outside hospitals and 123 of the cases were treated using LUCAS. The object was to evaluate the number of patients that regained spontaneous circulation (ROSC), i.e. their heart began to beat again on its own accord.

The study shows that the patients treated using LUCAS restored spontaneous circulation in 71 cases (57.7%). This group was then compared with a historical control group of 140 patients in 2004, when manual chest compressions were used. In that group, only 31 cases (22.14%) regained their circulation.

"The experience in Brussels supports our view that LUCAS fills an important function in emergency health care. LUCAS maintains the blood flow, which is of critical importance for saving the lives of patients suffering cardiac arrest," says Erik von Schenck, CEO of Jolife.

The study shows that LUCAS plays an important role in the resuscitation chain. Using LUCAS, the paramedics don't need to perform demanding manual compressions, but can focus on other tasks that are important to improve the chance of survival. It also means that high quality compressions can be performed during ambulance transportation without jeopardizing the safety of the paramedic response team.

"Several studies have shown that it is virtually impossible for a person to perform chest compressions as effectively and continuously as LUCAS is capable of. This is true wherever LUCAS is used – in a patient's home, in an ambulance or at a hospital. We see it as a quality assurance that improves the chance of survival from sudden cardiac arrest," says Jolife's CEO, Erik von Schenck.

An English translation of the article can be read on our homepage, Maule; Urgences & Accueil, Volume 7, Numéro 29, Juin-Juillet-Août 2007

The LUCAS™ chest compression system helps ambulance and hospital personnel to save patients suffering from sudden cardiac arrest by performing continuous chest compressions to maintain the blood flow to the brain and heart. International resuscitation guidelines issued in 2005 stress the importance of effective and uninterrupted chest compressions before defibrillation. LUCAS performs chest compressions in accordance with these guidelines without risking variations in quality or tiring out personnel. The device also allows safe transportation and permits simultaneous defibrillation and angiography.

About Jolife AB
Jolife is dedicated to increasing the survival of people suffering from sudden cardiac arrest, and the number who survive with their quality of life intact. This is being achieved by leading research and development in the field in order to offer innovative products which define the future for the treatment of sudden cardiac arrest. The company was founded in 2000 and has since worked closely with leading physicians and paramedics on research and development. This work has led to groundbreaking knowledge about the physiological effects of cardiac arrest and the importance of high-quality chest compressions. The LUCAS chest compression system is available for sale in the USA, Europe and various other parts of the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc. – a division within Medtronic Ltd., except in Sweden, Norway and Finland where it sells direct. For further information, please visit www.jolife.com or www.lucas-cpr.com

Jolife AB
Scheelevägen 17
223 70 Lund
Tel: +46 46 286 50 00

Latest news
Train on LUCAS™

Physio-Control Inc. / Jolife AB, Ideon Science Park, SE-223 70 Lund, Sweden, Tel: +46 (0) 46 286 50 00, Fax: +46 (0) 46 286 50 10, info@lucas-cpr.com
Powered by Publiciteta&Co